FDA Inspection 1315036 — ChemPacific Corporation

ChemPacific Corporation — FEI 3003299802

The FDA completed an inspection of ChemPacific Corporation on April 7, 2026 in Baltimore, MD. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 7, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Baltimore, MD (United States)